We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
Share this :
Print
GenScript Standard Stock (Omicron) - Multiplex sVNT
Genscript Standard Stock (Omicron) - Multiplex sVNT - GSCRPT (Additional S&H or Hazmat Fees May Apply)
List Price
$400.00
Your Price
$400.00
HOW MUCH YOU SAVE:
0.00 %
NETA PART: | GSCRPT-A02162-1 |
MFG.PART: | A02162-1 |
UNSPSC: | 12352203 |
Manufacturer: | GenScript USA Inc |
SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) is a positive-sense single-stranded RNA virus. It caused coronavirus disease 2019 (COVID-19). The B.1.1.529 variant was first reported to WHO from South Africa on 24 November 2021. WHO has designated B.1.1.529 as a VOC, named Omicron. SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells. Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. The blocking ability of SARS-CoV-2 neutralizing antibodies is affected by the quantity. This standard product is intended for the calibration of SARS-CoV-2 Omicron neutralizing antibodies. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 Omicron neutralizing antibodies. The neutralizing antibody standard binds to multiple neutralizing epitopes in the receptor-binding domain.
SKU | GSCRPT-A02162-1 |
---|---|
Supplier Part Number | A02162-1 |
UM | EA |
UNSPSC | 12352203 |
Manufacturer | GenScript USA Inc |
ProductLine | GSCRPT |
Qty | 1 |
MinOrderQty | 1 |
Weight | 7.00 |
Lead Time | 7 Business Days |
Hazardous | N |